Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 5, 2005 - Issue 1
Submit an article Journal homepage
30
Views
0
CrossRef citations to date
0
Altmetric
Review

Therapy of testicular cancer: a surgeon’s view

Shiva Dindyal The Royal London Hospital and The Homerton Hospital, Accident and Emergency, 18 Lowman Road, Holloway N7 6DD, UK. [email protected]
,
Neel Bhuva Faculty of Medicine, Imperial College London, South Kensington, London SW7 2AZ, UK. [email protected]
&
Prasanna Sooriakumaran Urology, Level A, The Royal Surrey County Hospital, Guildford, Surrey GU2 ZXX, UK. [email protected]
Pages 109-112 | Published online: 10 Jan 2014

References

  • Albers P, Christmas T. Testicular cancer. Eur. Urol.42, 1–8 (2003).
  • International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. J. Clin. Oncol.15, 594–603 (1997).
  • Oliver RTD, Mason M, Von der Maase H et al. A randomized trial of carboplatin versus radiotherapy for Stage I seminoma of the testis, following orchidectomy: MRCTE19/EORTC 30982. Br. J. Cancer91(Suppl. 1), S8–S23 (2004).
  • Clippe S, Flechon A, Droz JP. Cancer of the testis: role of radiotherapy in 2003. Cancer Radiother.7(Suppl. 1), 60S–69S (2003).
  • Pectasides D, Skarlos D, Dimopoulos AM et al. Two cycles of carboplatin based adjuvant chemotherapy for high-risk clinical Stage I and Stage IM non-seminomatous germ cell tumors of the testis: a HECOG trial. Anticancer Res.23(5b), 4239–4244 (2003).
  • Albers P, Perabo FG, Melchior D, Siener R. Adjuvant chemotherapy in Stage I and Stage II testicular cancer. World J. Urol.19, 76–81 (2001).
  • de Wit R. Treatment of disseminated non-seminomatous testicular cancer: the European experience. Semin. Surg. Oncol.17(4), 250–256 (1999).
  • Rick O, Bokemeyer C, Beyer J et al. Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer. J. Clin. Oncol.19, 81–88 (2001).
  • Hendry WF, A'Hern RP, Hetherington JW, Peckham MJ, Dearnaley DP, Horwich A. Para-aortic lymphadenectomy after chemotherapy for metastatic non-seminomatous germ cell tumors: prognostic value and therapeutic benefit. Br. J. Urol.7, 208–213 (1993).
  • Donohue JP, Thornhill JA, Foster RS, Bihrle R, Rowland RG, Einhorn LH. The role of retroperitoneal lymphadenectomy in clinical Stage B testis cancer: the Indiana University Experience (1965–1989). J. Urol.153, 85–89 (1995).
  • Laguna MP, Pizzocaro G, Klepp O, Algaba F, Kisbenedek L, Leiva O. EAU Working Group on Oncological Urology. EAU guidelines on testicular cancer. Eur. Urol.40, 102–110 (2001).
  • Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N. Engl. J. Med.337, 242–253 (1997).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.